199 related articles for article (PubMed ID: 1356055)
1. Toxic Graves' disease with thyroid hemiagenesis: diagnosis using thyroid-stimulating immunoglobulin measurements.
Shechner C; Kraiem Z; Zuckerman E; Dickstein G
Thyroid; 1992; 2(2):133-5. PubMed ID: 1356055
[TBL] [Abstract][Full Text] [Related]
2. Performance of Thyroid-Stimulating Immunoglobulin Bioassay and Thyrotropin-Binding Inhibitory Immunoglobulin Assay for the Diagnosis of Graves' Disease in Patients With Active Thyrotoxicosis.
Silva de Morais N; Angell TE; Ahmadi S; Alexander EK; Dos Santos Teixeira PF; Marqusee E
Endocr Pract; 2022 May; 28(5):502-508. PubMed ID: 35091101
[TBL] [Abstract][Full Text] [Related]
3. Development of Graves' hyperthyroidism from primary hypothyroidism in a case of thyroid hemiagenesis.
Bando Y; Nagai Y; Ushiogi Y; Toya D; Tanaka N; Fujisawa M
Thyroid; 1999 Feb; 9(2):183-7. PubMed ID: 10090320
[TBL] [Abstract][Full Text] [Related]
4. Serum thyrotropin in Graves' disease: a more reliable index of circulating thyroid-stimulating immunoglobulin level than thyroid function?
Kabadi UM; Premachandra BN
Endocr Pract; 2007 Oct; 13(6):615-9. PubMed ID: 17954417
[TBL] [Abstract][Full Text] [Related]
5. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
Chung YJ; Lee BW; Kim JY; Jung JH; Min YK; Lee MS; Lee MK; Kim KW; Chung JH
Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435
[TBL] [Abstract][Full Text] [Related]
6. Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels.
Khoo DH; Eng PH; Ho SC; Tai ES; Morgenthaler NG; Seah LL; Fong KS; Chee SP; Choo CT; Aw SE
Thyroid; 2000 Dec; 10(12):1093-100. PubMed ID: 11201855
[TBL] [Abstract][Full Text] [Related]
7. Graves' disease in a patient with thyroid hemiagenesis.
Levy EG
Thyroidology; 1989 Apr; 1(1):49-50. PubMed ID: 2484908
[TBL] [Abstract][Full Text] [Related]
8. Hemiagenesis of the thyroid gland.
Burman KD; Adler RA; Wartofsky L
Am J Med; 1975 Jan; 58(1):143-6. PubMed ID: 1172918
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of postpartum Graves' thyrotoxicosis from postpartum destructive thyrotoxicosis using antithyrotropin receptor antibodies and thyroid blood flow.
Ide A; Amino N; Kang S; Yoshioka W; Kudo T; Nishihara E; Ito M; Nakamura H; Miyauchi A
Thyroid; 2014 Jun; 24(6):1027-31. PubMed ID: 24400892
[TBL] [Abstract][Full Text] [Related]
10. Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism.
Romaldini JH; Bromberg N; Werner RS; Tanaka LM; Rodrigues HF; Werner MC; Farah CS; Reis LC
J Clin Endocrinol Metab; 1983 Sep; 57(3):563-70. PubMed ID: 6192139
[TBL] [Abstract][Full Text] [Related]
11. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
Tamaki H; Amino N; Aozasa M; Mori M; Tanizawa O; Miyai K
J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
[TBL] [Abstract][Full Text] [Related]
12. Thyroid hemiagenesis associated with Graves' disease and Graves' ophthalmopathy: case report.
Ozgen AG; Saygili F; Kabalak T
Thyroid; 2004 Jan; 14(1):75-7. PubMed ID: 15009918
[TBL] [Abstract][Full Text] [Related]
13. Relapse of Graves' disease after medical therapy: predictive value of thyroidal technetium-99m uptake and serum thyroid stimulating hormone receptor antibody levels.
Wilson R; McKillop JH; Pearson DW; Cuthbert GF; Thomson JA
J Nucl Med; 1985 Sep; 26(9):1024-8. PubMed ID: 2863338
[TBL] [Abstract][Full Text] [Related]
14. Similar effects of thionamide drugs and perchlorate on thyroid-stimulating immunoglobulins in Graves' disease: evidence against an immunosuppressive action of thionamide drugs.
Wenzel KW; Lente JR
J Clin Endocrinol Metab; 1984 Jan; 58(1):62-9. PubMed ID: 6196375
[TBL] [Abstract][Full Text] [Related]
15. A singular case of Graves' disease in congenital thyroid hemiagenesis.
Baldini M; Orsatti A; Cantalamessa L
Horm Res; 2005; 63(3):107-10. PubMed ID: 15775712
[TBL] [Abstract][Full Text] [Related]
16. [Thyroid gland hemiagenesis with Graves' disease].
Mikosch P; Gallowitsch HJ; Kresnik E; Lind P
Nuklearmedizin; 1999; 38(1):35-7. PubMed ID: 9987780
[TBL] [Abstract][Full Text] [Related]
17. Two cases of Graves' disease with presentation of unilateral diffuse uptake of radioisotopes.
Sakata S; Fuwa Y; Goto S; Fukui M; Yuasa H; Takuno H; Sarui H; Matsui I; Ogawa T; Sasano N
J Endocrinol Invest; 1993 Dec; 16(11):903-7. PubMed ID: 8144868
[TBL] [Abstract][Full Text] [Related]
18. Congenital thyroid hemiagenesis.
McHenry CR; Walfish PG; Rosen IB; Lawrence AM; Paloyan E
Am Surg; 1995 Jul; 61(7):634-8; discussion 638-9. PubMed ID: 7793746
[TBL] [Abstract][Full Text] [Related]
19. Low response of the thyroid gland to endogenous thyrotropin increased by thyrotropin-releasing hormone in patients with euthyroid Graves' disease.
Kashiwai T; Tada H; Watanabe Y; Shimaoka Y; Yagoro A; Hidaka Y; Fujikado T; Amino N
Thyroid; 1998 Oct; 8(10):881-5. PubMed ID: 9827654
[TBL] [Abstract][Full Text] [Related]
20. Hemiaplasia of the thyroid with thyrotoxicosis.
Mortimer PS; Tomlinson IW; Rosenthal FD
J Clin Endocrinol Metab; 1981 Jan; 52(1):152-5. PubMed ID: 7451642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
